Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	1.4960419950348682e-05	100.81761006289308	-216.95395722754864	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	1.4960419950348682e-05	116.26086956521739	-240.55570695978312	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	2.4021102428097927e-05	74.03703703703704	-172.05130589538587	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	5/181	1.2298084205616124e-06	2.4021102428097927e-05	44.84090909090909	-138.94613864677578	CXCL8;IL6;MYD88;STING1;TLR4
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	4.837683884850325e-05	53.12	-132.3420645012429	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Coronavirus disease	5/232	4.193632481505705e-06	4.837683884850325e-05	34.541850220264315	-110.54645043588327	CXCL8;IL6;MYD88;STING1;TLR4
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	4.837683884850325e-05	54.21768707482993	-134.5540755438832	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00012675084135305877	39.774436090225564	-104.03256013781805	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.0002184881273436549	33.37552742616034	-89.36652156273904	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00024891827281360785	31.349206349206348	-84.54495262531024	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.0003853134646413542	27.202072538860104	-74.37625984844887	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.000496949114370862	24.824644549763033	-68.34725873383007	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.0007120105326987338	21.287074829931974	-59.07439560833883	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0007120105326987338	37.99047619047619	-74.4091590745228	CXCL8;IL6;TLR4
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0007120105326987338	37.56828885400314	-73.71479219141467	CXCL8;IL6;LCN2
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0007120105326987338	21.55922865013774	-59.801482853342776	CXCL8;MYD88;STING1;TLR4
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0008539038513200551	34.497835497835496	-68.58379435140506	CXCL8;IL6;TLR4
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.0008542137696065006	33.806223479490804	-67.40758155759835	CXCL8;MYD88;TLR4
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.001902299827514156	24.99579831932773	-51.672386684351224	IL6;MYD88;TLR4
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.002962330850386124	57.378571428571426	-64.24352876962546	IL6;MYD88
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.0036564896912584066	19.106537530266344	-40.222430877266724	IL6;MYD88;TLR4
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.0055978212530138904	16.115516062884485	-34.04865723073064	MYD88;STING1;TLR4
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.006351795445788022	15.146718146718147	-31.989452913184095	CXCL8;IL6;STING1
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.007115698773763882	32.8155737704918	-41.182346051003734	IL6;STING1
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.007265671363419622	31.765873015873016	-40.07734547796954	IL6;TLR4
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.008084642966045727	29.41176470588235	-37.553176952571945	CXCL8;STING1
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.009388971154379184	26.643333333333334	-34.49723066158141	MYD88;TLR4
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.012021171423710685	22.933908045977013	-30.23706529396038	MYD88;TLR4
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.01407951207345864	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.01407951207345864	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.01610563398526473	18.600467289719628	-24.98176436194636	IL6;TLR4
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.016444428527405203	18.086363636363636	-24.33571316400054	MYD88;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.029239357576973383	12.933006535947712	-17.54750234216727	CXCL8;IL6
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.029239357576973383	12.847402597402597	-17.429441058365175	CXCL8;IL6
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.03804400388023531	6.556709956709956	-12.239051897711217	IL6;MYD88;STING1
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.0401807464057646	10.365789473684211	-13.920708621090329	CXCL8;IL6
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.0401807464057646	10.31020942408377	-13.840129933766221	CXCL8;IL6
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.04261271862590808	9.835	-13.147442958027579	IL6;MYD88
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.08180935552650768	22.3	-12.692261742471414	CXCL8
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.08180935552650768	21.75338753387534	-12.4264883862275	IL6
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.08180935552650768	6.6339590443686	-8.300944532041967	CXCL8;IL6
KEGG_2021_Human	ABC transporters	1/45	0.05436047130022726	0.08542359775749998	20.262626262626263	-11.690056551619103	DEFB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.08885149599908415	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.102428545627044	5.480113636363637	-6.479364551821025	IL6;TLR4
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.12231647452764782	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1521540730465538	9.961298377028713	-6.010407578745034	IL6
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.1567567141020397	9.425531914893616	-5.678293992521663	DEFB1
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.15960115584472395	9.036281179138323	-5.434068642481248	IL6
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.16305756470315097	8.592233009708737	-5.152341092635986	IL6
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.16305756470315097	8.2668743509865	-4.943743954376122	IL6
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.16305756470315097	8.345911949685535	-4.994589105830365	IL6
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.16547983951272024	7.964964964964965	-4.748494648054986	IL6
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.17034824345323268	3.5628544423440456	-3.410136075895621	CXCL8;IL6
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.18444554684452247	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.20269167881843847	5.987150415721844	-3.427000500776257	CXCL8
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.20400450566256056	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.2087811897124434	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.2087811897124434	5.562587904360056	-3.1333425612983894	TLR4
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2353049468824644	4.657210401891253	-2.4954112144854435	TLR4
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2353049468824644	4.5823152995927865	-2.441961042053517	CXCL8
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.24537256598697177	4.283224400871459	-2.2275706216550177	TLR4
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.2559432416168204	4.001019367991845	-2.0240281738454993	IL6
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.3049261303242888	3.184640522875817	-1.4307154955453085	IL6
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3196068134973313	2.9484262419416005	-1.2588658824557653	MYD88
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37938529609251864	2.32487922705314	-0.8103995559567543	IL6
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	IL6
